Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957))

Marta Bustaffa; Isabelle Koné-Paut; Seza Ozen; Gayane Amaryan; Efimia Papadopoulou-Alataki; Romina Gallizzi; Maria Carrabba; Yonatan Butbul Aviel; Luca Cantarini; Maria Alessio; Jordi Anton; Laura Obici; Faysal Gok; Ezgi Deniz Batu; Estefania Moreno; Paul Brogan; Maria Trachana; Gabriele Simonini; Donato Rigante; Yosef Uziel; Antonella Insalaco; Maria Cristina Maggio; Nicolino Ruperto; Marco Gattorno; L. Rossi Semerano

doi:10.1016/j.semarthrit.2022.152123

Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957))

Marta Bustaffa^*, Isabelle Koné-Paut, Seza Ozen, Gayane Amaryan, Efimia Papadopoulou-Alataki, Romina Gallizzi, Maria Carrabba, Yonatan Butbul Aviel, Luca Cantarini, Maria Alessio, Jordi Anton, Laura Obici, Faysal Gok, Ezgi Deniz Batu, Estefania Moreno, Paul Brogan, Maria Trachana, Gabriele Simonini, Donato Rigante, Yosef UzielAntonella Insalaco, Maria Cristina Maggio, Nicolino Ruperto, Marco Gattorno, L. Rossi Semerano

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957> <Marco Gattorno> <marcogattorno@gaslini.org>

Original language	English
Article number	152123
Journal	Seminars in Arthritis and Rheumatism
DOIs	https://doi.org/10.1016/j.semarthrit.2022.152123
State	Accepted/In press - 2022

Access to Document

10.1016/j.semarthrit.2022.152123

Fingerprint

Dive into the research topics of 'Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957))'. Together they form a unique fingerprint.

Cite this

Bustaffa, M., Koné-Paut, I., Ozen, S., Amaryan, G., Papadopoulou-Alataki, E., Gallizzi, R., Carrabba, M., Aviel, Y. B., Cantarini, L., Alessio, M., Anton, J., Obici, L., Gok, F., Batu, E. D., Moreno, E., Brogan, P., Trachana, M., Simonini, G., Rigante, D., ... Semerano, L. R. (Accepted/In press). Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)). Seminars in Arthritis and Rheumatism, [152123]. https://doi.org/10.1016/j.semarthrit.2022.152123

@article{c5f3c4289eba4b188809d4e36c23c992,

title = "Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957))",

abstract = "The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957> <Marco Gattorno> ",

author = "Marta Bustaffa and Isabelle Kon{\'e}-Paut and Seza Ozen and Gayane Amaryan and Efimia Papadopoulou-Alataki and Romina Gallizzi and Maria Carrabba and Aviel, {Yonatan Butbul} and Luca Cantarini and Maria Alessio and Jordi Anton and Laura Obici and Faysal Gok and Batu, {Ezgi Deniz} and Estefania Moreno and Paul Brogan and Maria Trachana and Gabriele Simonini and Donato Rigante and Yosef Uziel and Antonella Insalaco and Maggio, {Maria Cristina} and Nicolino Ruperto and Marco Gattorno and Semerano, {L. Rossi}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

doi = "10.1016/j.semarthrit.2022.152123",

language = "אנגלית",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders Ltd",

}

Bustaffa, M, Koné-Paut, I, Ozen, S, Amaryan, G, Papadopoulou-Alataki, E, Gallizzi, R, Carrabba, M, Aviel, YB, Cantarini, L, Alessio, M, Anton, J, Obici, L, Gok, F, Batu, ED, Moreno, E, Brogan, P, Trachana, M, Simonini, G, Rigante, D, Uziel, Y, Insalaco, A, Maggio, MC, Ruperto, N, Gattorno, M & Semerano, LR 2022, 'Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957))', Seminars in Arthritis and Rheumatism. https://doi.org/10.1016/j.semarthrit.2022.152123

Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life : Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)). / Bustaffa, Marta; Koné-Paut, Isabelle; Ozen, Seza et al.

In: Seminars in Arthritis and Rheumatism, 2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life

T2 - Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957))

AU - Bustaffa, Marta

AU - Koné-Paut, Isabelle

AU - Ozen, Seza

AU - Amaryan, Gayane

AU - Papadopoulou-Alataki, Efimia

AU - Gallizzi, Romina

AU - Carrabba, Maria

AU - Aviel, Yonatan Butbul

AU - Cantarini, Luca

AU - Alessio, Maria

AU - Anton, Jordi

AU - Obici, Laura

AU - Gok, Faysal

AU - Batu, Ezgi Deniz

AU - Moreno, Estefania

AU - Brogan, Paul

AU - Trachana, Maria

AU - Simonini, Gabriele

AU - Rigante, Donato

AU - Uziel, Yosef

AU - Insalaco, Antonella

AU - Maggio, Maria Cristina

AU - Ruperto, Nicolino

AU - Gattorno, Marco

AU - Semerano, L. Rossi

PY - 2022

Y1 - 2022

N2 - The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957> <Marco Gattorno>

AB - The authors regret < for the oversight to mention that this work has been done on behalf of the Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) >. The authors would like to apologise for any inconvenience caused. ____________________________ DOI of original article: < 10.1016/j.semarthrit.2022.151957> <Marco Gattorno>

UR - http://www.scopus.com/inward/record.url?scp=85142398457&partnerID=8YFLogxK

U2 - 10.1016/j.semarthrit.2022.152123

DO - 10.1016/j.semarthrit.2022.152123

M3 - תגובה / דיון

C2 - 36404149

AN - SCOPUS:85142398457

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

M1 - 152123

ER -

Bustaffa M, Koné-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R et al. Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957)). Seminars in Arthritis and Rheumatism. 2022;152123. doi: 10.1016/j.semarthrit.2022.152123

Corrigendum to The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort (Seminars in Arthritis and Rheumatism (2022) 52, (S0049017222000087), (10.1016/j.semarthrit.2022.151957))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this